UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Relationship between cobalamin and folate deficiencies and anemia in dogs

Journal of veterinary internal medicine, 2019-01, Vol.33 (1), p.106-113

2019

Volltextzugriff (PDF)

ACVIM consensus statement on the treatment of immune thrombocytopenia in dogs and cats

Journal of veterinary internal medicine, 2024-07, Vol.38 (4), p.1982-2007

2024

Volltextzugriff (PDF)

Canine platelet transfusions

Journal of veterinary emergency and critical care (San Antonio, Tex. : 2000), 2009-10, Vol.19 (5), p.401-415

2009

Volltextzugriff (PDF)

Clinical and clinicopathologic effects of plateletpheresis on healthy donor dogs

Transfusion (Philadelphia, Pa.), 2008-10, Vol.48 (10), p.2214-2221

2008

Volltextzugriff (PDF)

Evaluation of Iatrogenic Hypocortisolemia Following Trilostane Therapy in 48 Dogs with Pituitary-Dependent Hyperadrenocorticism

The Journal of the American Animal Hospital Association, 2021-09, Vol.57 (5), p.217-224

2021

Volltextzugriff (PDF)

Chicken Collagen X Regulatory Sequences Restrict Transgene Expression to Hypertrophic Cartilage in Mice

The American journal of pathology, 2004-02, Vol.164 (2), p.487-499

2004

Volltextzugriff (PDF)

Clinical findings, diagnostics and outcome in 33 cats with adrenal neoplasia (2002–2013)

Journal of feline medicine and surgery, 2016-02, Vol.18 (2), p.77-84

2016

Volltextzugriff (PDF)

Transient Acquired Fanconi Syndrome Associated with Copper Storage Hepatopathy in 3 Dogs

Journal of veterinary internal medicine, 2008-07, Vol.22 (4), p.1038-1042

2008

Volltextzugriff (PDF)

Inhibition of hypoxia-inducible factor-2α in renal cell carcinoma with belzutifan: a phase 1 trial and biomarker analysis

Nature medicine, 2021-05, Vol.27 (5), p.802-805

2021

Volltextzugriff (PDF)

Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma

Clinical cancer research, 2016-11, Vol.22 (22), p.5461-5471

2016

Volltextzugriff (PDF)

Randomized Trial of Olaparib With or Without Cediranib for Metastatic Castration-Resistant Prostate Cancer: The Results From National Cancer Institute 9984

Journal of clinical oncology, 2023-02, Vol.41 (4), p.871-880

2023

Volltextzugriff (PDF)

Phase I LITESPARK-001 study of belzutifan for advanced solid tumors: Extended 41-month follow-up in the clear cell renal cell carcinoma cohort

European journal of cancer (1990), 2024-01, Vol.196, p.113434-113434, Article 113434

2024

Volltextzugriff (PDF)

Author Correction: Inhibition of hypoxia-inducible factor-2α in renal cell carcinoma with belzutifan: a phase 1 trial and biomarker analysis

Nature medicine, 2021-10, Vol.27 (10), p.1849-1849

2021

Volltextzugriff (PDF)

CD8+ T Cells Impact Rising PSA in Biochemically Relapsed Cancer Patients Using Immunotherapy Targeting Tumor-Associated Antigens

Molecular therapy, 2020-05, Vol.28 (5), p.1238-1250

2020

Volltextzugriff (PDF)

Results From a Randomized Phase II Trial of Sunitinib and Gemcitabine or Sunitinib in Advanced Renal Cell Carcinoma with Sarcomatoid Features: ECOG-ACRIN E1808

Clinical genitourinary cancer, 2023-10, Vol.21 (5), p.546-554

2023

Volltextzugriff (PDF)

MP14-19 ARV-766, A PROTAC ANDROGEN RECEPTOR (AR) DEGRADER, COMBINED WITH ABIRATERONE IN NOVEL HORMONAL AGENT (NHA)-NA VE METASTATIC PROSTATE CANCER: PHASE 1 COHORT (PART C) OF A PHASE 1/2 STUDY

The Journal of urology, 2024-05, Vol.211 (5S)

2024

Volltextzugriff (PDF)

Evaluation of the Cunningham Panel™ in pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection (PANDAS) and pediatric acute-onset neuropsychiatric syndrome (PANS): Changes in antineuronal antibody titers parallel changes in patient symptoms

Journal of neuroimmunology, 2020-02, Vol.339, p.577138-577138, Article 577138

2020

Volltextzugriff (PDF)

Principal component analysis of a swine injury model identifies multiple phenotypes in trauma

The journal of trauma and acute care surgery, 2024-04, Vol.96 (4), p.634-640

2024

Volltextzugriff (PDF)

Randomized, double-blinded phase II study of ketoconazole (keto), hydrocortisone (HC), and anti-PSMA antibody J591 labeled with 177 Lu or 111 In in patients (pts) with high-risk non-metastatic (met) castration-resistant prostate cancer (M0 CRPC)

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.LBA21-LBA21

2023

Volltextzugriff (PDF)

Phase 1 LITESPARK-001 (MK-6482-001) study of belzutifan in advanced solid tumors: Update of the clear cell renal cell carcinoma (ccRCC) cohort with more than 3 years of total follow-up

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.4509-4509

2022

Volltextzugriff (PDF)

FFP maintains normal coagulation while Kcentra induces a hypercoagulable state in a porcine model of pulmonary contusion and hemorrhagic shock

The journal of trauma and acute care surgery, 2022-07, Vol.93 (1), p.124-129

2022

Volltextzugriff (PDF)

TAK-676: A Novel Stimulator of Interferon Genes (STING) Agonist Promoting Durable IFN-dependent Antitumor Immunity in Preclinical Studies

Cancer research communications, 2022-06, Vol.2 (6), p.489-502

2022

Volltextzugriff (PDF)

Inhibition of hypoxia-inducible factor-2[alpha] in renal cell carcinoma with belzutifan: a phase 1 trial and biomarker analysis

Nature medicine, 2021-05, Vol.27 (5), p.802

2021

Volltextzugriff (PDF)

The oral HIF-2 α inhibitor MK-6482 in patients with advanced clear cell renal cell carcinoma (RCC): Updated follow-up of a phase I/II study

Journal of clinical oncology, 2021-02, Vol.39 (6_suppl), p.273-273

2021

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(43)

Sprache

Englisch
(43)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Relationship between cobalamin and folate deficiencies and anemia in dogs

ACVIM consensus statement on the treatment of immune thrombocytopenia in dogs and cats

Canine platelet transfusions

Clinical and clinicopathologic effects of plateletpheresis on healthy donor dogs

Evaluation of Iatrogenic Hypocortisolemia Following Trilostane Therapy in 48 Dogs with Pituitary-Dependent Hyperadrenocorticism

Chicken Collagen X Regulatory Sequences Restrict Transgene Expression to Hypertrophic Cartilage in Mice

Clinical findings, diagnostics and outcome in 33 cats with adrenal neoplasia (2002–2013)

Transient Acquired Fanconi Syndrome Associated with Copper Storage Hepatopathy in 3 Dogs

Inhibition of hypoxia-inducible factor-2α in renal cell carcinoma with belzutifan: a phase 1 trial and biomarker analysis

Pediatric Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Clinical Presentation, Infectivity, and Immune Responses

Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma

Randomized Trial of Olaparib With or Without Cediranib for Metastatic Castration-Resistant Prostate Cancer: The Results From National Cancer Institute 9984

Phase I LITESPARK-001 study of belzutifan for advanced solid tumors: Extended 41-month follow-up in the clear cell renal cell carcinoma cohort

Author Correction: Inhibition of hypoxia-inducible factor-2α in renal cell carcinoma with belzutifan: a phase 1 trial and biomarker analysis

CD8+ T Cells Impact Rising PSA in Biochemically Relapsed Cancer Patients Using Immunotherapy Targeting Tumor-Associated Antigens

Results From a Randomized Phase II Trial of Sunitinib and Gemcitabine or Sunitinib in Advanced Renal Cell Carcinoma with Sarcomatoid Features: ECOG-ACRIN E1808

MP14-19 ARV-766, A PROTAC ANDROGEN RECEPTOR (AR) DEGRADER, COMBINED WITH ABIRATERONE IN NOVEL HORMONAL AGENT (NHA)-NA VE METASTATIC PROSTATE CANCER: PHASE 1 COHORT (PART C) OF A PHASE 1/2 STUDY

Evaluation of the Cunningham Panel™ in pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection (PANDAS) and pediatric acute-onset neuropsychiatric syndrome (PANS): Changes in antineuronal antibody titers parallel changes in patient symptoms

Principal component analysis of a swine injury model identifies multiple phenotypes in trauma

Randomized, double-blinded phase II study of ketoconazole (keto), hydrocortisone (HC), and anti-PSMA antibody J591 labeled with 177 Lu or 111 In in patients (pts) with high-risk non-metastatic (met) castration-resistant prostate cancer (M0 CRPC)

Phase 1 LITESPARK-001 (MK-6482-001) study of belzutifan in advanced solid tumors: Update of the clear cell renal cell carcinoma (ccRCC) cohort with more than 3 years of total follow-up

FFP maintains normal coagulation while Kcentra induces a hypercoagulable state in a porcine model of pulmonary contusion and hemorrhagic shock

TAK-676: A Novel Stimulator of Interferon Genes (STING) Agonist Promoting Durable IFN-dependent Antitumor Immunity in Preclinical Studies

Inhibition of hypoxia-inducible factor-2[alpha] in renal cell carcinoma with belzutifan: a phase 1 trial and biomarker analysis

The oral HIF-2 α inhibitor MK-6482 in patients with advanced clear cell renal cell carcinoma (RCC): Updated follow-up of a phase I/II study

Suchergebnisse filtern